Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV001536016 | SCV001752697 | likely pathogenic | Asphyxiating thoracic dystrophy 5; Nephronophthisis 13; Cranioectodermal dysplasia 4; Senior-Loken syndrome 8 | 2021-06-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003771654 | SCV004583223 | pathogenic | Asphyxiating thoracic dystrophy 5; Senior-Loken syndrome 8 | 2023-03-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr868Serfs*50) in the WDR19 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in WDR19 are known to be pathogenic (PMID: 22019273, 23559409, 23683095, 26275793, 27241786, 29068549). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with WDR19-related conditions. ClinVar contains an entry for this variant (Variation ID: 1179139). For these reasons, this variant has been classified as Pathogenic. |